Serum Levels of Annexin A2 as a Candidate Biomarker for Hepatic Fibrosis in Patients With Chronic Hepatitis B-Reference-Cited by-同舟云学术

Serum Levels of Annexin A2 as a Candidate Biomarker for Hepatic Fibrosis in Patients With Chronic Hepatitis B

Published:2015-10-24 Issue:10 Volume:15 Page:
ISSN:1735-143X
Container-title:Hepatitis Monthly
language:
Short-container-title:Hepat Mon

Author:

Kolgelier Servet,Demir Nazlim Aktug,Inkaya Ahmet Cagkan,Sumer Sua,Ozcimen Serap,Demir Lutfi Saltuk,Pehlivan Fatma Seher,Arslan Mahmure,Arpaci Abdullah

Publisher

Briefland

Subject

Infectious Diseases,Hepatology

Reference13 articles.

1. Natural History of Hepatitis B Virus Infection: An Update for Clinicians

2. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment

3. Proteomic analysis of primary duck hepatocytes infected with duck hepatitis B virus

4. Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cells

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening of common key immune genes and prediction of potential drugs in chronic hepatic injury;2024-01-19

2. The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2022-08

3. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs;International Journal of Biological Sciences;2022

4. Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma;Journal of Clinical Medicine;2021-09-15

5. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development;Journal of Clinical Medicine;2021-03-02